SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 148 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,577 | +40.1% | 3,725 | +9.5% | 0.00% | – |
| Q1 2023 | $2,553 | +86.5% | 3,403 | -8.1% | 0.00% | – |
| Q4 2022 | $1,369 | +36.9% | 3,701 | +68.8% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 2,193 | +1.7% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 2,157 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 2,157 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -99.9% | 2,157 | -99.8% | 0.00% | -100.0% |
| Q3 2021 | $2,060,000 | +397.6% | 944,969 | +756.2% | 0.00% | – |
| Q2 2021 | $414,000 | -59.3% | 110,373 | -64.7% | 0.00% | – |
| Q1 2021 | $1,018,000 | +5257.9% | 312,250 | +5531.2% | 0.00% | – |
| Q4 2020 | $19,000 | +5.6% | 5,545 | +25.0% | 0.00% | – |
| Q3 2020 | $18,000 | +5.9% | 4,437 | -10.5% | 0.00% | – |
| Q2 2020 | $17,000 | -81.7% | 4,960 | -87.5% | 0.00% | – |
| Q1 2020 | $93,000 | -25.0% | 39,738 | +16.4% | 0.00% | – |
| Q4 2019 | $124,000 | -91.7% | 34,144 | -81.1% | 0.00% | -100.0% |
| Q3 2019 | $1,500,000 | +3309.1% | 180,883 | +3450.9% | 0.00% | – |
| Q2 2019 | $44,000 | -26.7% | 5,094 | -8.8% | 0.00% | – |
| Q1 2019 | $60,000 | -96.7% | 5,588 | -97.3% | 0.00% | -100.0% |
| Q4 2018 | $1,809,000 | -64.7% | 206,756 | -32.3% | 0.00% | -50.0% |
| Q3 2018 | $5,129,000 | +11556.8% | 305,318 | +14522.5% | 0.00% | – |
| Q2 2018 | $44,000 | -98.9% | 2,088 | -99.2% | 0.00% | -100.0% |
| Q1 2018 | $4,188,000 | +187.6% | 260,308 | +238.7% | 0.00% | – |
| Q4 2017 | $1,456,000 | -26.1% | 76,861 | -45.1% | 0.00% | -100.0% |
| Q3 2017 | $1,970,000 | +185.1% | 140,018 | +50.8% | 0.00% | – |
| Q2 2017 | $691,000 | +95.8% | 92,844 | +71.2% | 0.00% | – |
| Q1 2017 | $353,000 | +100.6% | 54,218 | +36.6% | 0.00% | – |
| Q4 2016 | $176,000 | -45.8% | 39,699 | -42.9% | 0.00% | – |
| Q3 2016 | $325,000 | -50.2% | 69,488 | -30.0% | 0.00% | – |
| Q2 2016 | $652,000 | +150.8% | 99,317 | +142.8% | 0.00% | – |
| Q1 2016 | $260,000 | -80.9% | 40,904 | -81.9% | 0.00% | -100.0% |
| Q4 2015 | $1,360,000 | +268.6% | 225,609 | +265.6% | 0.00% | – |
| Q3 2015 | $369,000 | +954.3% | 61,711 | +1094.6% | 0.00% | – |
| Q2 2015 | $35,000 | +9.4% | 5,166 | -3.3% | 0.00% | – |
| Q1 2015 | $32,000 | -15.8% | 5,341 | +0.5% | 0.00% | – |
| Q4 2014 | $38,000 | – | 5,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |